Gilead Sciences shares are trading higher after the company announced it has initiated 2 Phase 3 studies of remdesivir in adults diagnosed with the Coronavirus.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.